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“31.4% of prescriptions were prescribed
six months or longer, only 51% had an
indication documented, and only 2% had
a review or stop date recorded.”

Ideas required

Antimicrobial resistance in aged-care
facilities requires a novel approach
Prof. Ramon Shaban, Prof. Brett Mitchell, Dr Philip Russo, Dr Deborough Macbeth*

The volume of antimicrobials
used in aged-care facilities
is startling and needs to
be addressed. The call for
research grants in this space
provides hope for the future.

W

e are ageing. More and more of
us are planning for, and accessing,
care in residential aged-care facilities
(RACFs). In Australia, the number of people
aged 80 and over — the group most likely
to require RACFs — is expected to double
from 3% of the population in 1998 to 6%
in 2031.1,2
Recent research
sheds light on
the extraordinary and startling use of
antimicrobials in RACF settings and the
complex factors contributing to this,
for which there are few original, ready
solutions. AURA 20166 and AURA 20177, the
first and second reports on antimicrobial
use in human health respectively, document
the extent of the AMR problem Australia
faces and the significant challenges we
all face. The extent of these issues was
3,4,5
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brought into sharp focus8 in the 2015 Aged
Care National Antimicrobial Prescribing
Survey (acNAPS), which called for
improvements in three main areas:
1. Better antimicrobial use documentation;
36% of prescriptions did not have an
indication recorded as to why they were
being used and 65.0% of prescriptions did
not have a review or stop date.

indication documented, and only 2% had a
review or stop date recorded.
Delivery care in RACFs is complex due to:
• the presenting conditions and infections
being chronic;
• delayed diagnosis and poorer clinical
outcomes3;
• the lack of or limited access to diagnostics;

2. Less use of antimicrobials for
unspecified infections;
17.5% of antimicrobials were being used for
unspecified skin infections.

• client placement in shared
accommodation, close living proximity and
frequent transfer in and out of acute care
settings.3,4,5

3. The need to review and reduce
prolonged prescription duration;
31.4% of prescriptions were prescribed
six months or longer, only 51% had an

These data paint a bleak picture,
demonstrating how complex and challenging
it is to achieve quality use of antimicrobials in
RACF settings.

hospitalhealth.com.au

Responding to the challenges of AMR and
antimicrobial use in RACFs requires novel and
original solutions. This need is highlighted by
the lack of RACF-specific AMR surveillance
and AMS programs to address the high levels
of inappropriate antimicrobial use.
News of the Australian Government’s recent
commitment to address these challenges
through the Medical Research Future Fund
Antimicrobial Resistance Targeted Call for
Research Grants is very encouraging.
These grants focus squarely on the
development of novel and innovative
approaches to containing and preventing
of AMR in residential and aged-care facilities
to the tune of $5.9 million.2 They seek to
stimulate research on novel and innovative
methodologies, such as genomics, to
determine antimicrobial resistance profiles and
transmission within and to/from RACFs. The
ultimate goal is to promote and develop optimal
and appropriate antimicrobial use in RACFs.
We, and our colleagues within the
Australasian College for Infection Prevention
and Control, welcome this new commitment
of the Australian Government. We look
forward to future opportunities for targeted
research that focuses specifically on other
non-antimicrobial solutions, specifically
infection prevention and control practices,
education and surveillance of infection in
RACFs more generally. These are inseparable
from the challenges of, and solutions to,
antimicrobial use and AMR.
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